ReviewThe journal of liquid biopsy2023

Liquid biopsy for assessment of RFS (recurrence-free survival) in NSCLC (non-small cell lung cancer) patients post-treatment through circulating tumour DNA detection: A meta-analysis.

Urvi Zala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.